newsit

KULR Scores Second Order from Major E-Commerce and Cloud Computing Giant for Drone Delivery

KULR Secures Second Order from Fortune 20 E-Commerce and Cloud Computing Customer for Commercial Drones San Diego, Aug. 18, 2022 (GLOBE NEWSWIRE) KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion (“Li-ion”) battery safety and thermal management technologies, has received two orders from a leading Fortune 20…

Read More

Breaking News: Ideal Power Announces Impressive Second Quarter 2022 Financial Results

Ideal Power Reports Second Quarter 2022 Financial Results About Ideal Power Inc. Ideal Power Inc. is a company pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN™ bidirectional semiconductor power switch. The company recently reported its financial results for the second quarter ended June 30, 2022. Financial Results During the second…

Read More

Perella Weinberg Partners: Registration Statement for Exchange Offer and Consent Solicitation on Warrants Now Effective!

Perella Weinberg Partners Announces Effectiveness of Registration Statement for Its Exchange Offer and Consent Solicitation New York, Aug. 15, 2022 (GLOBE NEWSWIRE) Perella Weinberg Partners (the “Company” or “PWP”) (NASDAQ: PWP), a leading global independent advisory firm, today announced that the registration statement on Form S-4 (the “Registration Statement”) filed by the Company with the…

Read More

Unveiling Workhorse Group’s Second Quarter 2022 Results: A Reflection on Growth, Impact, and Future Possibilities

Workhorse Group Reports Second Quarter 2022 Results CINCINNATI, Aug. 09, 2022 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) Management Commentary Workhorse Group Inc., an American technology company specializing in sustainable and cost-effective drone-integrated electric vehicles for last-mile delivery, announced their financial results for the second quarter ended June 30, 2022. The company’s management expressed…

Read More

Processa Pharmaceuticals Launches Website to Raise Awareness and Inform Patients of Ongoing Phase 2b Study of PCS499

Processa Pharmaceuticals Announces Launch of Website to Increase Awareness of Ulcerative Lipoid Necrobiosis Study HANOVER, MD, Aug. 04, 2022 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical need conditions, announces today…

Read More